HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of retinal vasodilator and constrictor responses in type 2 diabetes.

AbstractPURPOSE:
The retinal blood vessels provide a unique way to directly examine the human microvasculature, which is frequently damaged in individuals with diabetes. Previous studies have demonstrated that retinal flickering light-induced vasodilation and hyperoxia-induced vasoconstriction may operate by enhancing or reducing similar vasoregulatory factor(s), but a comparison between these two provocative stimuli in individuals with diabetes has not been studied. The purpose of the study was to examine the association between retinal flickering light-induced vasodilation and retinal hyperoxia-induced vasoconstriction in type 2 diabetic subjects and in healthy controls.
METHODS:
Twenty men and women with type 2 diabetes and 10 men and women without diabetes between 21 and 75 years of age were recruited. Changes in retinal artery and vein diameters to flickering light and during hyperoxia (100% oxygen) stimuli were measured on the same visit using a noninvasive retinal imaging device (Dynamic Vessel Analyzer, Imedos Inc., Germany).
RESULTS:
Compared with controls, diabetic subjects had impaired arterial vasodilator and vasoconstrictor responses to both flickering light and hyperoxia, respectively (both p<0.001). Merging both groups, an inverse correlation (r=-0.56; p=0.003) between the retinal artery's responses to flickering light-induced vasodilation and hyperoxia-induced vasoconstriction was demonstrated independent of glucose or insulin levels.
CONCLUSION:
This suggests that both responses are attenuated to a similar degree in diabetic subjects and that the attenuation to both stimuli can be observed in retinal arteries and veins. This would suggest that similar vasoregulatory factor(s) might in part help to explain the retinal diameter responses between the two stimuli. One suggested common vasoregulator of vascular tone is nitric oxide; however, other factor(s) may be involved, which contribute to this association and require further research.
AuthorsMary E J Lott, Julia E Slocomb, Vikram Shivkumar, Bruce Smith, Robert A Gabbay, David Quillen, Thomas W Gardner, Kerstin Bettermann
JournalActa ophthalmologica (Acta Ophthalmol) Vol. 90 Issue 6 Pg. e434-41 (Sep 2012) ISSN: 1755-3768 [Electronic] England
PMID22682034 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2012 The Authors. Acta Ophthalmologica © 2012 Acta Ophthalmologica Scandinavica Foundation.
Chemical References
  • Blood Glucose
  • Glycated Hemoglobin A
  • Insulin
  • Lipids
  • hemoglobin A1c protein, human
Topics
  • Adult
  • Aged
  • Blood Glucose (metabolism)
  • Blood Pressure (physiology)
  • Diabetes Mellitus, Type 2 (physiopathology)
  • Female
  • Glycated Hemoglobin (metabolism)
  • Heart Rate (physiology)
  • Humans
  • Hyperoxia (physiopathology)
  • Insulin (blood)
  • Lipids (blood)
  • Male
  • Middle Aged
  • Photic Stimulation
  • Regional Blood Flow
  • Retinal Vessels (physiopathology, radiation effects)
  • Vasoconstriction (physiology)
  • Vasodilation (physiology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: